Natera Says United States Supreme Court Denied CareDx's Petition For Certiorari Concerning Patent Infringement Lawsuit
Portfolio Pulse from Benzinga Newsdesk
The United States Supreme Court has denied CareDx's petition for certiorari concerning a patent infringement lawsuit against Natera. This final decision effectively terminates any existing claims brought by CareDx against Natera concerning these patents.
October 03, 2023 | 8:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
The Supreme Court's decision to deny CareDx's petition for certiorari concerning a patent infringement lawsuit against Natera effectively ends any existing claims brought by CareDx. This could potentially increase uncertainty for CareDx.
The Supreme Court's decision to deny CareDx's petition for certiorari ends the patent infringement lawsuit against Natera. This could potentially increase uncertainty for CareDx as they may have been relying on a positive outcome from this lawsuit. This negative news could have a negative impact on CareDx's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
The Supreme Court's decision to deny CareDx's petition for certiorari concerning a patent infringement lawsuit against Natera effectively ends any existing claims against Natera. This could potentially reduce legal expenses and uncertainty for Natera.
The Supreme Court's decision to deny CareDx's petition for certiorari ends the patent infringement lawsuit against Natera. This reduces the legal risk for Natera and could potentially lower their legal expenses. This positive news could have a positive impact on Natera's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100